OPTIMAL DOSAGE OF PRO-LEU-GLY-NH2 (MIF) IN NEUROPHARMACOLOGICAL TESTS AND CLINICAL USE

被引：29

作者：

BJORKMAN, S ^{[1
]}

SIEVERTSSON, H ^{[1
]}

机构：

[1] UNIV UPPSALA,CTR BIOMED,DEPT ORGAN PHARMACEUT CHEM,S-75123 UPPSALA,SWEDEN

来源：

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 1977年 / 298卷 / 02期

关键词：

D O I：

10.1007/BF00508614

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：79 / 81

页数：3

相关论文

共 17 条

[1] BARBEAU A, 1976, CAN MED ASSOC J, V114, P120
[2] BJORKMAN S, 1976, ACTA PHARM SUEC, V13, P289
[3] STUDIES ON INHIBITION OF OXOTREMORINE INDUCED TREMOR BY A MELANOCYTE-STIMULATING HORMONE RELEASE-INHIBITING FACTOR, THYROTROPIN RELEASING HORMONE AND RELATED PEPTIDES
CASTENSSON, S
SIEVERTSSON, H
LINDEKE, B
SUM, CY
[J]. FEBS LETTERS, 1974, 44 (01) : 101 - 105
[4] THE UP-AND-DOWN METHOD FOR SMALL SAMPLES
DIXON, WJ
[J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1965, 60 (312) : 967 - 978
[5] EFFECT OF MELANOCYTE-STIMULATING HORMONE-RELEASE INHIBITING FACTOR (MIF) IN PARKINSONS SYNDROME
FISCHER, PA
SCHNEIDER, E
JACOBI, P
MAXION, H
[J]. EUROPEAN NEUROLOGY, 1974, 12 (5-6) : 360 - 368
[6] FRIEDMAN AJ, 1973, SCIENCE, V182, P831
[7] GERSTENBRAND F, 1975, WIEN KLIN WOCHENSCHR, V87, P822
[8] INTENSIFICATION OF CENTRAL CATECHOLAMINERGIC AND SEROTONERGIC PROCESSES BY HYPOTHALAMIC FACTORS MIF AND TRF AND BY ANGIOTENSIN-II
HUIDOBROTORO, JP
SCOTTIDECAROLIS, A
LONGO, VG
[J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1975, 3 (02) : 235 - 242
[9] KASTIN AJ, 1972, CAN MED ASSOC J, V107, P1079
[10] ALPHA-MSH AND MIF-I EFFECTS ON CATECHOLAMINE LEVELS AND SYNTHESIS IN VARIOUS RAT-BRAIN AREAS
KOSTRZEWA, RM
KASTIN, AJ
SPIRTES, MA
[J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1975, 3 (06) : 1017 - 1023